AARP, Others Bash AstraZeneca's Drug Pricing Challenge

By Ruben Castaneda · November 9, 2023, 8:55 PM EST

Nine health care experts and the AARP in briefs filed Thursday asked a Delaware federal court to reject AstraZeneca's challenge to the Inflation Reduction Act's provision allowing the government to negotiate...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

AstraZeneca Pharmaceuticals LP v. Becerra et al

Case Number

1:23-cv-00931

Court

Delaware

Nature of Suit

Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision

Date Filed

August 25, 2023

Recent Articles By Ruben

February 13, 2024
Insurers Must Pay Pharma Co. Defense Costs In SEC Probe
February 08, 2024
FDA Settles Allegations Of Uneven Blood Treatment Standards
February 06, 2024
Sheppard Mullin Adds Partner From Faegre Drinker In Chicago
February 05, 2024
Tennessee Asks Justices To Keep Gender-Affirming Care Ban
January 31, 2024
FDA May Have To Cut Activities As Need to Regulate AI Grows
January 19, 2024
Ohio Court Blesses Atty's 'Zealous' Strategy, Axes Sanctions
January 05, 2024
NJ Brothers Ordered To Prison For Prescription Drug Scheme
January 04, 2024
Hospital Network Told To Provide Contracts In Antitrust Suit
December 20, 2023
Medical Device Cos. Settle Trade Secrets Suit For $8M
December 19, 2023
Anesthesiologists Say CMS Reimbursement Math Is Unlawful